University of Wisconsin Madison
University of Wisconsin Madison
Madison, Wisconsin, United States8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| American Lung Association (ALA) Lung Health Cohort | lung disorder, respiratory system disorder | Recruiting | Not stated | 2026-09-23 | NCT04543461 | |
| Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) | Charcot-Marie-Tooth disease type 1F, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Phase 3 | 2026-08-18 | NCT05147220 | |
| Wisconsin Brain Donor Program | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, psychiatric disorder, tauopathy | Enrolling by invitation | Not stated | 2026-08-14 | NCT00585572 | |
| Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy | Female Urogenital Diseases and Pregnancy Complications, Pregnancy Complications, Cardiovascular, Urogenital Diseases, cardiomyopathy, cardiovascular disorder, heart disorder, peripartum cardiomyopathy, pregnancy disorder | Recruiting | Phase 4 | 2026-08-10 | NCT05180773 | |
| AlloSure Lung Assessment and Metagenomics Outcomes Study | Lung Transplant Failure and Rejection; Lung Transplant Infection; Lung Transplant; Complications | Active, not recruiting | Not stated | 2026-06-25 | NCT05050955 | |
| Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS | Relapsing Multiple Sclerosis | Active, not recruiting | Phase 3 | 2026-05-27 | NCT03650114 | |
| Improving the Quality of Care for Asthma Patients at Risk of Exacerbations | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Not applicable | 2026-03-12 | NCT06596512 | |
| CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial | Angina Pectoris, Chest Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-01-06 | NCT03455725 |